SMTL ID : 5v19.1 (1 other biounit)

Structure-based drug design of novel ASK1 inhibitors using a fully integrated lead optimization strategy

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 3.10 Å

Oligo State

monomer

Ligands

1 x 8V4: N-(1-ethyl-1H-pyrazol-4-yl)furan-3-carboxamide(Non-covalent)

8V4.1: 11 residues within 4Å: Chain A: L.17, V.25, A.38, V.69, M.85, E.86, Q.87, V.88, G.91, L.141, S.152 5 PLIP interactions: 5 interactions with chain A Hydrophobic interactions: A:A.38, A:V.69, A:L.141 Hydrogen bonds: A:V.88, A:G.91

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Gibson, T.S. et al., Structure-based drug design of novel ASK1 inhibitors using an integrated lead optimization strategy. Bioorg. Med. Chem. Lett. (2017)

Release Date

2017-03-29

Peptides

Mitogen-activated protein kinase kinase kinase 5: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Mitogen-activated protein kinase kinase kinase 5

Related Entries With Identical Sequence